MAXORPTION
Live / Registered — Registered (as of 30 Dec 2025)
What this means for you
Registered since 30 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79407494
- Registration number
- 8081611
- Mark type
- Stylized text
- Filed
- 29 Jul 2024
- Published for opposition
- 11 Nov 2025
- Registered
- 30 Dec 2025
- Attorney of record
- Michael F. Swartz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations containing omega 3 for treatment of cardiovascular diseases, cognitive decline, and inflammatory disorders; dietetic foods for medical use containing oils rich in EPA and DHA for treating dyslipidemia, metabolic syndrome, and neurodevelopmental disorders; nutritional supplements for human consumption for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular and metabolic disorders namely hypertriglyceridemia, metabolic syndrome, and type 2 diabetes, neurological and cognitive decline namely Alzheimer's disease and mild cognitive impairment, mood and psychiatric disorders namely depression and anxiety, inflammatory and autoimmune conditions namely rheumatoid arthritis and inflammatory bowel disease, and ophthalmic disorders namely dry eye syndrome and age-related macular degeneration; ophthalmic preparations containing omega-3; food supplements for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular diseases namely hypertriglyceridemia and atherosclerosis, neurodegenerative disorders namely Alzheimer's disease and cognitive decline, psychiatric conditions namely depression and anxiety, inflammatory and autoimmune diseases namely rheumatoid arthritis, and for supporting maternal and infant health namely healthy pregnancy, reduction of risk of preterm birth, optimal fetal brain and retinal development, and post-partum mental health; food supplements for specialized nutrition, infant nutrition; Nutraceuticals containing oils rich in EPA and DHA, targeting the microbiota for treating inflammatory bowel disease, irritable bowel syndrome and metabolic inflammation and intestinal dysbiosis; Nutritional dietetic food additives for medical, paramedical or pharmaceutical use in the nature of natural food extracts derived from fish; food supplements containing omega-3; food supplements derived from microalgae or marine oils
Owner
Prosecution history
- 30 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 30 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Apr 2025 — REFUSAL PROCESSED BY IB
- 17 Mar 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB